Sean M. Clayton is EVP, General Counsel of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 7,655 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $891,807. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Sean M. Clayton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2023
SELL
Sale (or disposition) back to the issuer
$891,807 $116.5 p/Share
7,655 Reduced 100.0%
0 Ordinary Shares
Mar 01 2023
SELL
Payment of exercise price or tax liability
$775,910 $110.34 p/Share
7,032 Reduced 48.81%
7,376 Ordinary Shares
Mar 01 2023
BUY
Exercise of conversion of derivative security
-
14,129 Added 49.51%
14,408 Ordinary Shares
SMC

Sean M. Clayton

EVP, General Counsel
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP